Alternatively, the differential phosphorylation of EphA2 determines the effect on tumorigenesis; EphA2-S897 phosphorylation promotes tumorigenesis [20], while EphA2-Y772 phosphorylation decreases transendothelial cell migration of cancer cells [22]. The gene discussed is EPHA2; the disease is cancer.